Target Health and Ferring Pharmaceuticals Presenting on CTMS

Silvana Cappi, Executive Director Global Biometrics at Ferring International PharmaScience Center (Copenhagen) and Dr. Jules T. Mitchel, President of Target Health will be presenting at CBI’s 4th Annual Clinical Trial Management Systems (CTMS) meeting , March 24-25, 2011, Crowne Plaza, Philadelphia. Our session on “Analysis of the Decision Whether to Co-Develop a CTMS with an eCRO or to Buy an Existing Application”, provides the clinical operations and IT professional with insight into the development of a CTMS system that was not purchased off the shelf. FDA will also be speaking on “Understand Potential Regulatory Issues and Inspection Expectations.”

As the only forum dedicated solely to discussion regarding CTMS systems, this program offers the unique opportunity for industry collaboration among various CTMS stakeholders. Featuring industry case studies and perspectives from Sanofi-Aventis, Merck & Co., Inc., Millennium: The Takeda Oncology Company and GlaxoSmithKline, to name a few, this program offers a balanced perspective of the different types of CTMS systems utilized by the industry.

For more information about this meeting and/or Target Health contact Warren Pearlson (212-681-2100 ext. 104). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel or Ms. Joyce Hays. Target Health’s software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health website at:


Leave a Reply

You must be logged in to post a comment.